LS

Luigi Piero Stasi

NA Nuevolution A/S: 7 patents #11 of 58Top 20%
RS Rottapharm Biotech S.R.L.: 7 patents #2 of 22Top 10%
GL Glaxo Group Limited: 3 patents #340 of 1,368Top 25%
📍 Monza, IT: #15 of 427 inventorsTop 4%
Overall (All Time): #190,091 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Showing 1–22 of 22 patents

Patent #TitleCo-InventorsDate
12344606 Next-generation modulators of stimulator of interferon genes (STING) Magdalena Izabela ZAWADZKA, Maciej Krzysztof ROGACKI, Grzegorz Wojciech CWIERTNIA, Lukasz Piotr Dudek, Monika Patrycja Dobrzanska +6 more 2025-07-01
11780843 Compounds active towards nuclear receptors Sanne Schrøder Glad, Ian Sarvary, Alex Haahr Gouliaev, Thomas Franch, Montserrat Erra Sola +2 more 2023-10-10
11685727 Compounds active towards nuclear receptors Sanne Schrøder Glad, Ian Sarvary, Alex Haahr Gouliaev, Thomas Franch, Søren Jensby Nielsen +5 more 2023-06-27
11613532 Compounds active towards nuclear receptors Sanne Schrøder Glad, Ian Sarvary, Alex Haahr Gouliaev 2023-03-28
11447479 Compounds active towards nuclear receptors Sanne Schrøder Glad, Ian Sarvary, Alex Haahr Gouliaev, Thomas Franch, Søren Jensby Nielsen 2022-09-20
11254681 Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases Sanne Schrøder Glad, Niels Grøn Nørager, Ian Sarvary, Alex Haahr Gouliaev, Lene Teuber 2022-02-22
10975081 Substituted fused pyrazole compounds and their use as LRRK2 inhibitors Xiao Ding, Yun Jin, Qian Liu, Feng Ren, Yingxia Sang +5 more 2021-04-13
10689383 Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases Sanne Schrøder Glad, Kim Birkebæk Jensen, Niels Grøn Nørager, Ian Sarvary, Mikkel VESTERGAARD +2 more 2020-06-23
10683293 Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases Sanne Schrøder Glad, Niels Grøn Nørager, Ian Sarvary, Alex Haahr Gouliaev, Lene Teuber 2020-06-16
10618901 LRRK2 inhibitors for the treatment of Parkinson's disease Xiao Ding, Qian Liu, Yingxia Sang, Zehong Wan, Baowei Zhao +1 more 2020-04-14
10087186 Compounds as LRRK2 kinase inhibitors Xiao Ding, Zehong Wan, Colin Michael Edge 2018-10-02
9815841 Compounds Xiao Ding, Qian Liu, Kai Long, Yingxia Sang, Zehong Wan +2 more 2017-11-14
9498478 Spiro aminic compounds with NK1 antagonist activity Lucio Claudio Rovati 2016-11-22
9181279 Cyclic amine derivatives as EP4 receptor antagonists Manuela Borriello, Sabrina Pucci, Lucio Claudio Rovati 2015-11-10
9174977 2-azabicyclo[4.1.0]heptane derivatives as orexin receptor antagonists for the treatment of certain disorders Lucio Claudio Rovati 2015-11-03
9120824 Cyclic amine derivatives as EP4 receptor agonists Manuela Borriello, Sabrina Pucci, Lucio Claudio Rovati 2015-09-01
9062033 Chemical compounds Lucio Claudio Rovati, Roberto Artusi, Fabrizio Colace, Stefano Mandelli, Lorenzo Perugini 2015-06-23
8859608 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction Lucio Claudio Rovati 2014-10-14
8828987 Pyridine amide derivatives as EP4 receptor antagonists Manuela Borriello, Lucio Claudio Rovati, Benedetta Buzzi, Fabrizio Colace 2014-09-09
7732600 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors Markus Bergauer, Barbara Bertani, Matteo Biagetti, Steven Mark Bromidge, Alessandro Falchi +7 more 2010-06-08
7592346 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors Markus Bergauer, Barbara Bertani, Matteo Biagetti, Steven Mark Bromidge, Alessandro Falchi +7 more 2009-09-22
7459456 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors Matteo Biagetti, Alessandro Falchi, Colin Philip Leslie, Giancarlo Merlo, Domenica Antonia Pizzi +2 more 2008-12-02